FI45970C - Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi. - Google Patents
Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi.Info
- Publication number
- FI45970C FI45970C FI650534A FI53465A FI45970C FI 45970 C FI45970 C FI 45970C FI 650534 A FI650534 A FI 650534A FI 53465 A FI53465 A FI 53465A FI 45970 C FI45970 C FI 45970C
- Authority
- FI
- Finland
- Prior art keywords
- nitroimidazoles
- aryl
- substituted
- preparation
- therapeutically valuable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/93—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by halogen atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US350639A US3399211A (en) | 1964-03-10 | 1964-03-10 | Production of 2-aryl-4(5)-nitroimidazoles |
| US72464968A | 1968-02-02 | 1968-02-02 | |
| US84374969A | 1969-07-22 | 1969-07-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI45970B FI45970B (fi) | 1972-07-31 |
| FI45970C true FI45970C (fi) | 1972-11-10 |
Family
ID=27407957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI650534A FI45970C (fi) | 1964-03-10 | 1965-03-04 | Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi. |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US3399211A (fi) |
| BE (1) | BE660836A (fi) |
| BR (1) | BR6567675D0 (fi) |
| CH (1) | CH479589A (fi) |
| DE (3) | DE1795462A1 (fi) |
| DK (3) | DK118718B (fi) |
| FI (1) | FI45970C (fi) |
| FR (2) | FR1605151A (fi) |
| GB (1) | GB1104412A (fi) |
| IL (2) | IL22948A (fi) |
| IT (1) | IT1046100B (fi) |
| NL (1) | NL143923B (fi) |
| NO (1) | NO121445B (fi) |
| SE (2) | SE339231B (fi) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7017486A (fi) * | 1969-12-15 | 1971-06-17 | ||
| US3624093A (en) * | 1970-03-10 | 1971-11-30 | American Home Prod | 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols |
| GB1347493A (en) * | 1971-02-11 | 1974-02-27 | Aspro Nicholas Ltd | Benzazine derivatives |
| US3976778A (en) * | 1973-08-13 | 1976-08-24 | Ciba-Geigy Corporation | Imidazoles and processes for their production |
| DE2400887A1 (de) * | 1974-01-09 | 1975-08-28 | Bayer Ag | Verfahren zur herstellung von nitroderivaten aromatischer verbindungen |
| DE2414280C2 (de) * | 1974-03-25 | 1981-12-17 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von 1-Methyl-5-nitroimidazolen |
| EG11928A (en) * | 1974-12-16 | 1979-03-31 | Hoechst Ag | Process for preparing of 1-alkyl-2-(phenoxy-methyl)-5-nitro-imidazoles |
| US4065572A (en) * | 1976-02-13 | 1977-12-27 | Merck & Co., Inc. | Amino acids and esters thereof useful as antihypertensive agents |
| US4156734A (en) * | 1976-02-13 | 1979-05-29 | Merck & Co., Inc. | Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid |
| US4235995A (en) * | 1978-09-25 | 1980-11-25 | Eli Lilly And Company | 3-Nitropyrazole derivatives |
| US4314844A (en) * | 1979-01-11 | 1982-02-09 | Rohm And Haas Company | Herbicidal substituted imidazoles |
| US4423046A (en) * | 1982-04-05 | 1983-12-27 | Sterling Drug Inc. | Antibacterial and antiprotozoal 1-methyl-5-nitro-2-(2-phenylvinyl)imidazoles |
| US5206257A (en) * | 1987-03-05 | 1993-04-27 | May & Baker Limited | Pesticidal method using 2-phenylimidazole derivatives |
| GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
| US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| US6613789B2 (en) | 1994-07-28 | 2003-09-02 | G. D. Searle & Co. | Heterocyclo-substituted imidazoles for the treatment of inflammation |
| TW200400004A (en) * | 2002-05-22 | 2004-01-01 | Novartis Ag | Organic compounds |
| WO2006092430A1 (de) * | 2005-03-03 | 2006-09-08 | Universität des Saarlandes | Selektive hemmstoffe humaner corticoidsynthasen |
| US11319291B1 (en) | 2020-06-09 | 2022-05-03 | United States Of America As Represented By The Secretary Of The Air Force | Continuous flow microfluidic process for synthesis of 3,4-dinitropyrazole |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2933503A (en) * | 1957-01-14 | 1960-04-19 | Merck & Co Inc | Benzimidazole derivatives |
| US2963504A (en) * | 1958-06-09 | 1960-12-06 | American Cyanamid Co | Alkyl toluene diisocyanates |
| US3162675A (en) * | 1961-09-19 | 1964-12-22 | Dow Chemical Co | Process for making nitroaromatic nitriles |
| US3121092A (en) * | 1962-01-29 | 1964-02-11 | Abbott Lab | Pyrazole derivative |
-
1964
- 1964-03-10 US US350639A patent/US3399211A/en not_active Expired - Lifetime
-
1965
- 1965-02-09 IL IL22948A patent/IL22948A/en unknown
- 1965-02-09 IL IL31076A patent/IL31076A/xx unknown
- 1965-03-01 GB GB8652/65A patent/GB1104412A/en not_active Expired
- 1965-03-04 FI FI650534A patent/FI45970C/fi active
- 1965-03-05 DE DE19651795462 patent/DE1795462A1/de active Pending
- 1965-03-05 DE DE19651795452 patent/DE1795452A1/de active Pending
- 1965-03-05 DE DE1795699A patent/DE1795699B2/de active Granted
- 1965-03-08 IT IT5043/65A patent/IT1046100B/it active
- 1965-03-09 NO NO157118A patent/NO121445B/no unknown
- 1965-03-09 SE SE15927/68A patent/SE339231B/xx unknown
- 1965-03-09 BE BE660836D patent/BE660836A/xx unknown
- 1965-03-09 FR FR1605151D patent/FR1605151A/fr not_active Expired
- 1965-03-09 BR BR167675/65A patent/BR6567675D0/pt unknown
- 1965-03-09 SE SE15926/68A patent/SE355185B/xx unknown
- 1965-03-10 DK DK122665AA patent/DK118718B/da unknown
- 1965-03-10 CH CH330065A patent/CH479589A/de not_active IP Right Cessation
- 1965-03-10 NL NL656503046A patent/NL143923B/xx not_active IP Right Cessation
- 1965-06-08 FR FR19927A patent/FR4677M/fr not_active Expired
-
1966
- 1966-05-25 DK DK267966AA patent/DK118508B/da unknown
- 1966-05-25 DK DK268066AA patent/DK115704B/da unknown
-
1968
- 1968-02-02 US US724649*A patent/US3487087A/en not_active Expired - Lifetime
-
1969
- 1969-07-22 US US00843749A patent/US3719759A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR1605151A (fi) | 1973-03-23 |
| SE339231B (fi) | 1971-10-04 |
| DE1595926A1 (de) | 1970-07-09 |
| US3399211A (en) | 1968-08-27 |
| IT1046100B (it) | 1980-06-30 |
| DE1595926B2 (de) | 1975-04-03 |
| US3487087A (en) | 1969-12-30 |
| NL143923B (nl) | 1974-11-15 |
| DE1795452A1 (de) | 1970-12-17 |
| FI45970B (fi) | 1972-07-31 |
| US3719759A (en) | 1973-03-06 |
| FR4677M (fi) | 1966-12-19 |
| CH479589A (de) | 1969-10-15 |
| DE1795699C3 (fi) | 1975-12-18 |
| DK118718B (da) | 1970-09-28 |
| GB1104412A (en) | 1968-02-28 |
| DE1795699A1 (de) | 1973-10-11 |
| BE660836A (fi) | 1965-09-09 |
| DK118508B (da) | 1970-08-31 |
| IL22948A (en) | 1969-06-25 |
| DE1795462A1 (de) | 1972-01-13 |
| DE1795699B2 (de) | 1975-04-30 |
| NO121445B (fi) | 1971-03-01 |
| SE355185B (fi) | 1973-04-09 |
| BR6567675D0 (pt) | 1973-08-14 |
| DK115704B (da) | 1969-11-03 |
| IL31076A (en) | 1969-06-25 |
| NL6503046A (fi) | 1965-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI47364C (fi) | Menetelmä terapeuttisesti arvokkaiden 3-indolyyli-alifaattinen-happoyh disteiden valmistamiseksi. | |
| FI45970C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi. | |
| FI48722C (fi) | Menetelmä 3-metyylipenteenien valmistamiseksi. | |
| FI46069C (fi) | Menetelmä terapeuttisesti käytettävän 1-R-2-formyyli-5-nitroimidatsoli n valmistamiseksi. | |
| DK115400B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner. | |
| NL148915B (nl) | Werkwijze voor de bereiding van poly-epsilon-caprolactam. | |
| FI45180C (fi) | Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi. | |
| DK121708B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater. | |
| FI46965C (fi) | Menetelmä 5-fenyyli-1,4-bentsodiatsepiini-4-oksidien valmistamiseksi | |
| OA03369A (fr) | Procédé de préparation de benzène-sulfonyl-urées. | |
| FI44625C (fi) | Menetelmä uusien terapeuttisesti arvokkaiden d-treo-1-fenyyli-2-amino-1,3-propaanidiolijohdannaisten valmistamiseksi | |
| FI43878C (fi) | Menetelmä antidiabeettisesti tehokkaiden 2-bentseenisulfonamidopyrimidiinien valmistamiseksi | |
| DK117488C (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner. | |
| FI44620C (fi) | Menetelmä sulfamyyliantraniilihappoamidien valmistamiseksi. | |
| DK115694B (da) | Fremgangsmåde til fremstilling af α-dithioler. | |
| DK111891B (da) | Fremgangsmåde til fremstilling af 5-oxo-17α-methyl-20-hydroxy-(des-A)-19-nor-pregna-9-en. | |
| DK122071B (da) | Analogifremgangsmåde til fremstilling af methylenbutyrylphenoler. | |
| FI45954C (fi) | Menetelmä terapeuttisesti vaikuttavien bentseenisulfonyylivirtsa-ainei den valmistamiseksi. | |
| FI45332C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-aroyyli-2-substituoitu-5-subst ituoitu-3-indolietikkahappojen valmistamiseksi. | |
| FI46726C (fi) | Menetelmä uusien terapeuttisesti käytettävien nor-3alfa- tai 3beta-tro panolin atsoniaspiraanien tai niiden estereiden valmistamiseksi. | |
| FI48738C (fi) | Tapa valmistaa terapeuttisesti arvokkaita oksadiatsolijohdannaisia. | |
| FI45047C (fi) | Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi. | |
| FI43312C (fi) | Menetelmä trans-4-aminometyylisykloheksaani-1-karbonihapon valmistamiseksi | |
| DK106860C (da) | Fremgangsmåde til fremstilling af N-alkanoylamino-5-nitro-2-furamidiner. | |
| DK106186C (da) | Fremgangsmåde til fremstilling af 17α-ethoxy-6-chlor-6-dehydro-progesteron. |